Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai

Figure 2

Genomic features and clinical outcome according to groups. (a) The differences in phylogenetic analysis across the various groups. The genomes sequenced at the time of the second wave form distinct clusters as compared to the first wave. The genomes from unvaccinated, dose 1, and dose 2 groups do not show significant differences. (b) Box and dot plots depicting the median number of mutations across different groups. (c) The bar chart showing the distribution of COVID-19 patients according to severity at the time of the second wave of the pandemic.

(a)

(b)

(c)